MedTrace Logo

Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy

NCT05997004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-08-28

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the incidence of bradycardia during laparoscopic cholecystectomy. The main question\[s\] it aims to answer are:

* Does bradycardia really occurs during pneumoperitoneum/laparoscopic surgery?
* If the patient get Glycopyrrolate, Does it really prevent pneumoperitoneum/laparoscopic surgery induced bradycardia?

Conditions

  • Bradyarrhythmia
  • Cardiac Arrest
  • Tachycardia
  • Asystole

Interventions

DRUG

Normal Saline

After surgical creation of umbilical port Control group received injection normal saline 1ml.

DRUG

Glycopyrrolate

After surgical creation of umbilical port Group II received injection Glycopyrrolate 1ml=0.2mg

Sponsors & Collaborators

  • National Academy of Medical Sciences, Nepal

    lead OTHER_GOV

Principal Investigators

  • Brihaspati K C, MD · NAMS Bir Hospital

  • Brahmadev Jha, MD · NAMS Bir Hospital

  • Surendra Bhusal, MD · NAMS Bir Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2019-05-20
Completion
2019-11-15

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05997004 on ClinicalTrials.gov